BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18299890)

  • 1. Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas.
    Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T
    Virchows Arch; 2008 Apr; 452(4):377-82. PubMed ID: 18299890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men.
    Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T
    Pathol Int; 2008 Aug; 58(8):477-82. PubMed ID: 18705766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.
    Paluszczak J; Misiak P; Wierzbicka M; Woźniak A; Baer-Dubowska W
    Oral Oncol; 2011 Feb; 47(2):104-7. PubMed ID: 21147548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization.
    Bai LX; Wang JT; Ding L; Jiang SW; Kang HJ; Gao CF; Chen X; Chen C; Zhou Q
    Asian Pac J Cancer Prev; 2014; 15(21):9313-7. PubMed ID: 25422218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
    Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer.
    Gutiérrez MI; Siraj AK; Khaled H; Koon N; El-Rifai W; Bhatia K
    Mod Pathol; 2004 Oct; 17(10):1268-74. PubMed ID: 15154012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine.
    Liu WB; Ao L; Zhou ZY; Cui ZH; Zhou YH; Yuan XY; Xiang YL; Cao J; Liu JY
    Biochem Biophys Res Commun; 2010 Nov; 402(3):507-14. PubMed ID: 20970405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
    Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients.
    Laytragoon-Lewin N; Chen F; Castro J; Elmberger G; Rutqvist LE; Lewin F; Turesson I; Lundgren J
    Anticancer Res; 2010 Nov; 30(11):4643-8. PubMed ID: 21115918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
    Shi HR; Wu QH; Suo ZH; Nesland JM
    Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
    Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
    Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area.
    Guo XQ; Wang SJ; Zhang LW; Wang XL; Zhang JH; Guo W
    J Exp Clin Cancer Res; 2007 Dec; 26(4):587-94. PubMed ID: 18365557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
    Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
    Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
    Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
    Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.